Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This chapter reviews common drug-related and systemic disorder-induced alopecias, focusing on their epidemiology, causes, symptoms, diagnosis, and treatment, but reports no new findings.

This case study describes a Doberman Pinscher with a unique alopecic variant of chronic cutaneous lupus erythematosus that progressed to systemic lupus erythematosus, highlighting a rare autoimmune alopecia form in dogs.

This review discusses the basic principles of hair pathology and findings in common types of alopecia but reports no new research results.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

This review outlines current treatments for folliculitis decalvans and dissecting cellulitis of the scalp, noting conventional therapies' limitations and promising but limited results from targeted biologic agents.

In this study, cicatricial alopecias were classified by inflammatory cell type and the researchers highlighted that primary cicatricial alopecia's exact causes remain unknown, accounting for 6% of all hair diseases despite its unclear prevalence.

This review discusses the characteristics and treatment options for abscessing undermining folliculitis and Hoffman's perifolliculitis, concluding that isotretinoin is currently the most effective treatment but reports no new clinical results.

This study reported that in mouse models, deletion of EGFR resulted in stem cell hyper-proliferation followed by apoptosis, leading to scarring alopecia, and implicated EGFR's role in maintaining hair follicle quiescence and immune privilege during inflammation.

This report describes a case of sclero-atrophy localized to the frontal scalp following an injection of botulinum toxin type A, which has not been previously documented in the literature.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

In this case study, a 62-year-old male with a history of uncontrolled diabetes and chronic kidney disease was diagnosed with perforating folliculitis after presenting with dark, raised, pruritic lesions on his limbs, confirmed by histopathological examination showing collagen extruding into hair follicles.

This study suggests that seborrhoeic folliculitis may represent a unique form of cicatricial alopecia, linking chronic scalp dermatitis-folliculitis with low-grade inflammatory fibrosing alopecia.

This case study highlights an unusual presentation of folliculitis decalvans by age and sex, emphasizing early diagnosis due to its chronic nature and irreversible consequences.

In this case report, a 40-year-old woman with folliculitis decalvans exhibits symptoms like itchy papules and patchy hair loss, illustrating the importance of distinguishing this condition from similar scarring alopecias for appropriate treatment.

In this study, a 63-year-old male with chronic acne necrotica achieved complete clinical remission using topical erythromycin and benzoyl peroxide.

This study found that dermatological adverse events from interferon-alpha/ribavirin treatment for chronic hepatitis C are associated with factors like older age, pre-existing skin conditions, cirrhosis, and the use of pegylated interferon formulations.

The EADV Task Force on Hair Diseases reviewed existing literature and clinical experience to propose diagnostic and therapeutic recommendations for managing folliculitis decalvans, highlighting oral antibiotics, glucocorticosteroids, isotretinoin, and various systemic and topical therapies as key options for managing inflammation and preventing further hair loss.

This article discusses the proposed role of immunologic responses to staphylococcal superantigens in folliculitis decalvans and reports no clinical results; treatment should be tailored to the disease's severity.

This review discusses the potential role of Demodex mites in various human skin conditions, including acneiform eruptions and folliculitis, but reports no new research findings.

This case report describes a patient with folliculitis decalvans who successfully responded to photodynamic therapy.

This article reviews the characteristics, pathogenesis, and treatment strategies for folliculitis decalvans, emphasizing the importance of early recognition and treatment to mitigate hair loss, but reports no new clinical results.

This case report describes a 16-year-old with ectrodactyly-ED-clefting syndrome, where scarring alopecia with follicular involvement appeared during puberty, possibly due to anatomic hair abnormalities.

This report on identical female twins with folliculitis decalvans suggests a possible genetic component to the disease, marking the first such case in twins.

This case report describes an adult patient with tinea capitis due to Microsporum canis who experienced complete hair regrowth following treatment with fluconazole and ketoconazole shampoo.

This review discusses biphasic alopecia, where non-scarring forms like traction alopecia and androgenetic alopecia may progress to follicle destruction, emphasizing the role of chronic inflammation and the importance of clinician-pathologist collaboration, but provides no new clinical results.

This study examined the clinicopathologic and trichoscopic characteristics of keratosis follicularis spinulosa decalvans and identified terminal hair involvement and follicular hyperkeratosis as key diagnostic features.

In this study conducted at a tertiary dermatological clinic, researchers identified and described the clinical, dermoscopic, and histopathological features of preclinical folliculitis keloidalis, including novel dermoscopic findings such as perifollicular scale, which was associated with fibrosis.

This study found that various treatment combinations for folliculitis decalvans generally led to clinical improvement and hair regrowth in male patients, though relapse was common after treatment cessation.

This review discusses the challenge of managing folliculitis decalvans, agreeing that treatment aims to stop inflammation and hair loss but noting that achieving results is difficult and may require long-term therapy.

This review outlines the diagnosis and management of folliculitis decalvans, an inflammatory scalp disorder, and highlights Staphylococcus aureus and immune response deficiencies as key factors in its development.